Developments in T-cell depletion of allogeneic stem cell grafts

Current Opinion in Hematology

Volumn 7, Issue 6, 2000, Pages 348-352

  Cornelissen, Jan J ^a   Löwenberg, Bob ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033784506     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200011000-00005     Document Type: Review

References (29)

1. T-cell depletion for the prevention of graft-versus-host disease
2. Selective removal of alloreactive cells from haematopoietic stem cell grafts: Graft engineering for GVHD prophylaxis
3. Graft tolerance: A duel of two signals
4. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host
5. Transplantation of anergic histoincompatible bone marrow allografts
6. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
7. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T-lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease
8. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
9. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand
10. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets
11. Adoptive immunotherapy in canine chimeras
12. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase-chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation
13. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion
14. T-cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect
15. Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation
16. Prevention of relapse after lymphocyte depleted allogeneic bone marrow transplantation by preemptive donor leukocyte infusions in patients with high risk of relapse
17. Immunological reconstitution following hematopoietic stem cell transplantation
18. Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions
19. Immune reconstitution following T-cell depleted bone marrow transplantation: Effect of age and post-transplant graft rejection prophylaxis
20. Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells
21. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia
22. Improved immune reconstitution after allotransplantation of periopheral blood stem cells instead of bone marrow
23. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts
24. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: Comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts
25. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts, unselected PBPC grafts or BM grafts
26. T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny
27. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
28. Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients
29. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study